MSF joins Europe-wide action challenging patent on key hepatitis C drug

Rome/Geneva, – Médecins Sans Frontières (MSF) has today filed a patent challenge on the hepatitis C drug sofosbuvir with the European Patient Office (EPO) in an effort to increase access to affordable hepatitis C treatment. MSF has joined Médecins du Monde (MdM) and other civil society organisations from 17 countries in simultaneously filing patent challenges on the pharmaceutical corporation Gilead’s monopoly on sofosbuvir, in a bid to remove the barrier

European regulator amends some Gilead hep C patent claims

In a setback for Gilead Sciences, European regulators decided not to uphold all of its patent claims for the best-selling Sovaldi hepatitis C treatment, a move that could lead to generic versions of the medicine becoming available four years sooner than had been expected. The European Patent Office on Tuesday amended several patent claims that were challenged by Medicins Du Monde, a medical aid charity, which argued that Gilead was abusing the patent sy...

Hepatitis C: Gilead patent on sofosbuvir partially maintained following MdM patent opposition

European Patent Office (EPO) has taken its decision following Doctors of the World - Médecins du Monde (MdM) patent opposition on Gilead Sciences’ Sofosbuvir. MdM applauds EPO’s decision to revoke partially the patent. MdM has filled an opposition on the patent granted to Gilead Sciences for Sofosbuvir (Sovaldi®) on February 10th, 2015. A patent opposition is a legal procedure by means of which the validity of a patent can be challenged because the drug...

mapCrowd Launch

Dear friends, colleagues, and fellow advocates,Médecins du Monde (MdM) and Treatment Action Group (TAG) are pleased to announce the launch of mapCrowd (, an innovative online resource and data collection platform for gathering and sharing hepatitis C information. Following a successful trial period in which we obtained data from 23 countries, we are now making mapCrowd publicly available so that experts and advocates from other countries